Sucampo Pharmaceuticals Provides Update on Anticipated Arbitration Decision; The ICC Extends Date to July 31
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that the International Court of Arbitration, International Chamber of Commerce (ICC) has notified the Company of a change in the anticipated date of the decision related to the Company's demand for arbitration under the applicable provisions of the Collaboration and License Agreement with Takeda Pharmaceuticals Company Limited, or Takeda.
The ICC has extended the date from June 29, 2012 to July 31, 2012. Sucampo does not know how long thereafter the proceedings will conclude.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.